
Releases
Zoetis Investors Targeted in Securities Fraud Class Action
Investors who held Zoetis Inc. shares between January 14, 2025, and May 6, 2026, face a critical window to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging that the company misled the market regarding the performance and safety of its core veterinary drug portfolio.























